Capital International Inc’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-862,789
Closed -$10.9M 304
2021
Q3
$10.9M Sell
862,789
-12,844
-1% -$178K 0.1% 154
2021
Q2
$13.5M Sell
875,633
-37,598
-4% -$632K 0.12% 147
2021
Q1
$18.5M Sell
913,231
-42,156
-4% -$1.04M 0.17% 130
2020
Q4
$25.9M Sell
955,387
-18,506
-2% -$415K 0.24% 114
2020
Q3
$18M Sell
973,893
-13,707
-1% -$243K 0.2% 122
2020
Q2
$17.6M Hold
987,600
0.21% 121
2020
Q1
$9.09M Buy
+987,600
New +$14.7M 0.15% 119

Other funds holding CLLS

Capital International Inc's CLLS Position: Q4 2021 in Review

Capital International Inc sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 862,789 shares — an estimated $10.9M sold.

Capital International Inc first reported a position in CLLS in Q1 2020 and held it in 7 quarters. The position peaked at $25.9M in Q4 2020. 56 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Capital International Inc reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Capital International Inc sold 862,789 Cellectis shares in Q4 2021, an estimated $10.9M.
  • Capital International Inc first reported a position in Cellectis in Q1 2020 and held it in 7 quarters.
  • Capital International Inc's Cellectis position peaked at $25.9M in Q4 2020.
  • 56 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Capital International Inc's 13F filing for Q4 2021, filed 14 Feb 2022.